Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 Mga view
• 07/10/23
0
0
I-embed
administrator
Mga subscriber
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento